NASDAQ •
Healthcare •
Medical Devices •
Quote as of 07/17/2026
Company Profile
IndustryMedical Devices
SectorHealthcare
ExchangeNASDAQ
Market Capitalization581.07 mln
Float28.44 mln
Earnings Date08/12/2026
EPS
0.22
Overpriced
P / E
71.50
Richly valued
Piotroski F-Score
6
/ 9
Solid
Beneish M-Score
-0.34
Highly suspicious
1-Year Forecast
17.50
Modest upside
Relative Strength
87
/ 100
Strongly outperforming
Business Description
Founded in Jerusalem in 2003, BrainsWay designs and markets a brain stimulation technology that treats a wide range of mental health and neurological conditions without surgery or medication. Its core device uses deep magnetic fields to target specific areas of the brain, helping patients with conditions such as depression, OCD, addiction, PTSD, and Parkinson's disease, among others. The company works with psychiatrists, hospitals, and medical centers across the United States, East Asia, and other markets worldwide.
